MigraineScience
Sun, Jan 04, 26
Long-Term Safety of Anti-CGRP Monoclonal Antibodies
A comprehensive meta-analysis of over 4,300 patients reveals that erenumab, galcanezumab, fremanezumab, and eptinezumab maintain good tolerability beyond 12 months. Only 3% of patients stopped treatment due to adverse events,...
Read MoreThu, Jan 01, 26
Alternate Nostril Breathing Protocol for Migraine
Alternate nostril breathing is a simple yogic technique that's showing real promise for migraine prevention. Unlike acute treatments, this practice builds nervous system resilience over time - making attacks less...
Read MoreFri, Dec 26, 25
Why Migraine and Jaw Pain Go Together: New Research (2025) Explains the Link
A 2025 systematic review of over 10,000 patients confirms a strong bidirectional link between migraine and temporomandibular disorders. People with migraine are 6 times more likely to develop TMD, while...
Read MoreSat, Dec 20, 25
Eptinezumab (Vyepti) Desensitization Protocol
First-ever eptinezumab (Vyepti) desensitization protocol for migraine patients with hypersensitivity reactions. 10-step hospital-based approach proven safe and effective.
Read MoreWed, Dec 17, 25
Migraine Management During Pregnancy, Breastfeeding, and Pregnancy Planning
This guide provides comprehensive, evidence-based recommendations for migraine management throughout the reproductive journey.
Read MoreMon, Nov 17, 25
Migraine Research - During the week of my absence.
Migraine Research - During the week of my absence. The Association Between Insomnia and Migraine Disability and Quality of Life This study examined how insomnia severity relates to migraine disability...
Read MoreSat, Nov 01, 25
Anti-CGRP Monoclonal Antibody Migraine Treatment: Super-Responders and Absolute Responders and When to Expect Results
Anti-CGRP monoclonal antibodies achieved 70% super-response and 23% complete migraine freedom in a one-year study. Most dramatic improvements occurred after 6 months of treatment. For patients with chronic or high-frequency...
Read MoreAll Non-Invasive Neuromodulation Devices for Migraine Treatment
Wondering if migraine devices actually work? This guide breaks down the latest evidence on non-invasive neuromodulation devices like Cefaly, Nerivio, and gammaCore. Learn which devices have solid research backing them,...
Read MoreSun, Sep 14, 25
Neuroimaging Differences Between Migraine Types: Aura vs. Without Aura
Discover the latest neuroimaging research revealing key brain differences between migraine with aura and migraine without aura.
Read MoreThu, Sep 04, 25
Understanding Migraine Prodrome
Discover the migraine prodrome phase: 36 warning symptoms that occur 1-6 hours before headache onset. Learn timing patterns, predictive confidence levels, and new treatment approaches based on groundbreaking 2025 research...
Read MoreThu, Aug 07, 25
Dizziness and Migraine: When is it Vestibular Migraine?
Dizziness and migraine: Learn when dizziness is vestibular migraine vs BPPV, Meniere's disease, or vascular causes. Guide covers symptoms, diagnosis, cutaneous allodynia, and treatment options for recurrent dizziness episodes.
Read MoreMon, Aug 04, 25
Evidence-Based Guide to Migraine Nutraceuticals and Herbal Options
Evidence-based guide to natural migraine treatments including riboflavin, magnesium, ginger, and CoQ10. Compare effectiveness, dosing, and safety of 15+ nutraceuticals and herbal remedies for migraine prevention and acute treatment with...
Read MoreMon, Jul 28, 25
Status Migrainosus Guide: A migraine attack lasting 72 hours or more
Status migrainosus is a severe migraine complication lasting over 72 hours requiring emergency treatment. Learn evidence-based management strategies, IV therapy protocols, diagnostic criteria, and prognosis from this comprehensive clinical guide...
Read MoreFri, Jul 25, 25
Understanding Cutaneous Allodynia in Migraine
Learn about skin hypersensitivity affecting 63% of migraine patients, validated assessment tools, suicide risks, and how allodynia predicts treatment response. Evidence-based insights from major population studies including AMPP and MAST...
Read MoreWed, Jul 23, 25
Choosing Migraine Medications Based on Administration Routes
Complete guide to migraine drug delivery methods: oral tablets, nasal sprays, injections & topical treatments. Compare onset times, effectiveness & side effects for optimal migraine relief. Includes latest options like...
Read MoreTue, Jul 15, 25
Abdominal Migraine in Children and Adults
Abdominal migraine causes recurring episodes of severe stomach pain with nausea, vomiting, and pallor in children and adults. Learn about symptoms, diagnosis, treatment options, and how this condition differs from...
Read MoreSun, Jul 13, 25
The Hidden Connection: Migraine and Hypothyroidism (Overt and Subclinical)
Discover the proven connection between migraine and hypothyroidism. Learn how thyroid treatment reduces migraine frequency by 78% and why doctors now recommend routine thyroid screening for chronic headache patients.
Read MoreFri, Jul 11, 25
Migraine and Depression: Shared Brain Mechanisms
Learn why migraine and depression are linked through shared brain pathways. 2025 research reveals genetic connections and dual-action treatments for both.
Read MoreMon, Jul 07, 25
Chronic Pain and Brain Gene Expression
New study proves chronic pain is biological. Brain immune cells drive pain, offering hope for targeted migraine and chronic pain treatments.
Read MoreSat, Jul 05, 25
Migraine & White Matter Hyperintensities
Migraine and white matter hyperintensities: Recent studies show NO association. Large-scale 2023-2025 research contradicts older findings. Important clinical implications explained.
Read MoreWed, Jul 02, 25
Endocannabinoid System Genetics Breakthrough in Medication Overuse Headache
Breakthrough genetics study reveals FAAH gene changes in medication overuse headache. Endocannabinoid DNA differences could transform diagnosis and treatment.
Read More
